2020 Central Clinical School Public Lecture
Hope for patients living with ‘The Sacred Disease’
How translational research on epilepsy is closing the treatment gap
You are invited to attend the annual CCS public lecture. In 2020, the lecture will be presented by Professor Terry O'Brien, Head of Central Clinical School and its Departments of Neuroscience and Medicine.
Epilepsy is a lifelong neurological condition estimated to affect over 65 million people worldwide, and in Australia, an estimated 100,000 suffer from epilepsy. Approximately one third of people with epilepsy do not respond to drug treatment and their quality of life is greatly affected by the unpredictability and severity of seizures. Epilepsy is complex to understand and treat, as it has a variety of causes and manifests in a variety of ways. Accordingly, research programs to discover new treatments to better control and manage epilepsy are diverse. They include genetics, pharmacology, neuropsychiatry, neuropsychology, surgery and dietary therapies. Our research is closing the treatment gap.
About our speaker
Professor Terry O'Brien is Head of Monash University's Central Clinical School and Program Director Alfred Brain and Deputy Director of Research, Alfred Health. He is a specialist in neurology and clinical pharmacology, with particular expertise in epilepsy and neurodegenerative diseases, neuropharmacology, pre-clinical and clinical drug development, and in-vivo imaging in animal models and humans. Professor O'Brien leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments and biomarkers for people with epilepsy and related brain diseases, including traumatic brain injury, dementias and brain tumours. He has published >495 peer-reviewed original papers in leading scientific and medical journals which have been cited >19,400 times (H-Index 73).